Association between Sialyl Lewisa Expression and Tumor Progression in Melanoma

Cancer Research

Volumn 55, Issue 8, 1995, Pages 1748-1751

  Kageshita, Toshiro ^a   Hirai, Shunji ^a   Kimura, Toru ^a   Hanai, Nobuo ^b   Ohta, So ^b   Ono, Tomomichi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL LINE; COMPARATIVE STUDY; GANGLIOSIDES; HUMAN; IMMUNOENZYME TECHNIQUES; MELANOCYTES; MELANOMA; NEOPLASM METASTASIS; NEVUS, PIGMENTED; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0028985944     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Matsushita, Y., Hoff, S. D., Nudelman, E. D., Otaka, M.,Hakomori, S., Ota, D. M., Cleary, K. R., and Irimura, T. Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Lex antigen. Clin. Exp. Metastasis, 9: 283–299, 1991.
2. Matsushita, Y., Nakamori, S., Seftor, E. A., Hendrix, M. J. G., and Irimura, T. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric Lex antigen. Exp. Cell Res., 196: 20–25, 1991.
3. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Kabuto, T., Iwanaga, T., Matsushita, Y., and Irimura, T. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res., 53: 3632–3637, 1993.
4. Fukushima, K. Expression of Lewisx, sialylated Lewisa, Lewisa and sialylated Lewisa antigens in human lung carcinoma. Tohoku J. Exp. Med., 163: 17-30, 1991.
5. Sugiyama, K., Kawai, T., Nagata, N., and Suzuki, M. Tumor-associated carbohydrate antigens in primary pulmonary adenocarcinomas and their metastases. Hum. Pathol., 23: 900–904, 1992.
6. Stone, J. P., and Wagner, D. D. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J. Clin. Invest., 92: 804–813, 1993.
7. Kunzendorf, U., Kruger-Krasagakes, S., Notter, M., Hock, H., Walz, G., and Diamantstein, T. A sialyl-Lex-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res., 54: 1109–1112, 1994.
8. Shitara, K., Hanai, N., and Yoshida, H. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. Cancer Res., 47: 1261–1212, 1987.
9. Hanai, N., Furuya, A., Shitara, K., Oda, S., and Yoshida, H. Comparative studies on monoclonal antibodies raised against human cancer for application to serum diagnosis of cancer. Anticancer Res., 8: 329–334, 1988.
10. Maio, M., Gulwani, B., Langer, J. A., Kerbel, R. S., Duigou, G. J., Fisher, P. B., and Ferrone, S. Modulation by interferons of HLA antigen, high-molecular-weight melanoma-associated antigen and intercellular adhesion molecule-1 expression by cultured melanoma cells with different metastatic potential. Cancer Res., 49: 2980–2987, 1989.
11. Iliopoulos, D., Ernst, C., Steplewski, Z., Jambrosic, J. A., Rodeck, U., Herlyn, M., Clark, W. H., Jr., Koprowski, H., and Herlyn, D. Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J. Natl. Cancer Inst., 81: 440–444, 1989.
12. Houghton, A. N., Eisinger, M., Albino, A. P., Cairncross, J. G., and Old, L. J. Surface antigens of melanocytes and melanomas. J. Exp. Med., 156: 1755–1766, 1982.
13. Hanai, N., Nores, G. A., MacLeod, C., Torres-Mendez, C. A., and Hakomori, S. Ganglioside-mediated modulation of cell growth. J. Biol. Chem., 263:10915–10921, 1988.
14. Hanai, N., Shitara, K., Furuya, A., Yoshida, H., Dohi, T., Nudelman, E., Hakomori, S., and Satoh, S. Detailed characterization of reactivities of anti-gastric cancer monoclonal antibodies to carbohydrate antigen. Anticancer Res., 10: 1579–1586, 1990.
15. Dohi, T., Nemoto, T., Ohta, S., Shitara, K., Hanai, N., Nudelman, E., Hakomori, S., and Ohshima, M. Different binding properties of three monoclonal antibodies to sialyl Lex glycolipids in a gastric cancer cell line and normal stomach tissue. Anticancer Res., 13: 1277–1282, 1993.
16. Temponi, M., Kageshita, T., Perosa, F., Ono, R., Okada, H., and Ferrone, S. Purification of murine IgG monoclonal antibodies by precipitation with caprylic acid: comparison with other methods of purification. Hybridoma, 8: 85–95, 1989.
17. Kageshita, T., Nakamura, T., Yamada, M., Kuriya, N., Arao, T., and Ferrone, S. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions. Cancer Res., 57; 1726–1732, 1991.
18. Magnai, J., Brocklaus, M., Smith, D., Ginsburg, V., Blaszcyk, M., Mitchell, D., Steplewski, Z., and Koprowski, H. A monoclonal antibody defined antigen of colon carcinoma. Science (Washington DC), 272: 55–56, 1982.
19. Fukushi, Y., Nudelman, E., Levery, S. B., Hakomori, S., and Rauvala, H. Novel focolipids accumulating in human adenocarcinoma III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside. J. Biol. Chem., 259: 10511–10517, 1984.
20. Fukushi, Y., Kannagi, R., Hakomori, S., Shepard, T., Kulander, B. G., and Singer, J. W. Location and distribution of difucoganglioside in normal and tumor tissue defined by its monoclonal antibody FH6. Cancer Res., 45: 3711–3717, 1985.
21. Beahrs, O. H., Henson, D. E., Hurler, R. V. P., and Kennedy, B. J. (eds). Manual for Staging of Cancer: American Joint Committee on Cancer, Ed. 4, pp. 143–148. Philadelphia: J. B. Lippincott Co., 1992.
22. Arends, J. W., Wiggers, T., Verstijnen, C., Hilgers, J., and Bosman, F. T. Gastrointestinal cancer-associated antigen (GIGA) immunoreactivity in colorectal carcinoma in relation to potent survival. Int. J. Cancer, 34: 193–196, 1984.
23. Ernst, C. S., Shen, J-W., Litwin, S., Herlyn, M., Koprowski, H., and Sears, H. F. Multiparameter evaluation of the expression in situ of normal and tumor-associated antigens in human colorectal carcinoma. J. Natl. Cancer Inst., 77: 387–395, 1986.
24. Wigger, T., Arends, J. W., Schutte, B., Vovovics, L., and Bosman, F. T. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer (Phila.), 61: 386–395, 1988.
25. Kusano, A., Ohta, S., Shirata, K., and Hanai, N. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies. Anticancer Res., 13: 2207–2212, 1993.
26. Johnson, J. P., Stade, B. G., Holzman, B., Schwable, W., and Riethmuller, G. De novo expression of intercellular adhesion molecule-1 in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. USA, 86: 641–644, 1989.
27. Natali, P. G., Nicotra, M. R., Cavaliere, R., Bigotti, A., Romano, G., Temponi, M., and Ferrone, S. Differential expression of intercellular adhesion molecule-1 in primary and metastatic melanoma lesions. Cancer Res., 50: 1271–1278, 1990.
28. Kageshita, T., Yoshii, A., Kimura, T., Kuriya, N., Ono, T., Tsujisaki, M., Imai, K., and Ferrone, S. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res., 53: 4927-4932, 1993.
29. Albelda, S. M., Mette, S. A., Elder, D. E., Stewart, R. M., Damjanovich, L., Herlyn, M., and Buck, C. A. Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res., 50: 6757–6764, 1990.
30. Becker, J. C., Dummer, R., Hartmann, A. A., Burg, G., and Schmidt, R. E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-γ and tumor necrosis factor-α. J. Immunol., 147: 4398–4401, 1991.